litlas
Log inCreate account

Mark E. Anderson

Active 1994–2025

Also published as
Mark E Anderson
108
Papers
17,947
Citations
83
h-index
107
i10-index

Citations

Citations per year for Mark E. Anderson1995: 1 citations1996: 1 citations1997: 5 citations1998: 3 citations1999: 24 citations2000: 22 citations2001: 36 citations2002: 48 citations2003: 43 citations2004: 74 citations2005: 77 citations2006: 126 citations2007: 102 citations2008: 131 citations2009: 196 citations2010: 191 citations2011: 285 citations2012: 294 citations2013: 308 citations2014: 343 citations2015: 294 citations2016: 263 citations2017: 196 citations2018: 205 citations2019: 559 citations2020: 719 citations2021: 580 citations2022: 466 citations2023: 326 citations2024: 460 citations2025: 209 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,121 citing papers, 31.7% of this breakdownChina: 758 citing papers, 11.3% of this breakdownGermany: 438 citing papers, 6.6% of this breakdownUnited Kingdom: 421 citing papers, 6.3% of this breakdownItaly: 268 citing papers, 4% of this breakdownCanada: 255 citing papers, 3.8% of this breakdownFrance: 235 citing papers, 3.5% of this breakdownNetherlands: 203 citing papers, 3% of this breakdownJapan: 200 citing papers, 3% of this breakdownSpain: 134 citing papers, 2% of this breakdownAustralia: 119 citing papers, 1.8% of this breakdownSwitzerland: 95 citing papers, 1.4% of this breakdown
0%31.7%Other 21.6%

Institutions

Fields

  • Medicine49.3%
  • Biochemistry, Genetics and Molecular Biology36.7%
  • Neuroscience4.4%
  • Engineering2.1%
  • Nursing1.8%
  • Immunology and Microbiology1.6%
  • Other4.1%

Topics

  • Cardiac electrophysiology and arrhythmias10.6%
  • Ion channel regulation and function6.8%
  • Mitochondrial Function and Pathology3.2%
  • Cardiomyopathy and Myosin Studies2.7%
  • Cardiovascular Function and Risk Factors2.3%
  • Neuroscience and Neuropharmacology Research2%
  • Other72.4%

Coauthors

All papers

Open in search
  1. A Dynamic Pathway for Calcium-Independent Activation of CaMKII by Methionine Oxidation

    Authors: Jeffrey R. Erickson, Mei-ling A. Joiner, Xiaoqun Guan, William Kutschke, Jinying Yang, Carmine V. Oddis, Ryan K. Bartlett, J. S. Lowe, Susan E. O’Donnell, Nükhet Aykin‐Burns, Matthew C. Zimmerman, Kathy Zimmerman, Amy‐Joan L. Ham, Robert M. Weiss, Douglas R. Spitz, M. A. Shea, Roger Colbran, Peter J. Mohler, Mark E. Anderson - Cell 2008 cited by 1,117

  2. CaMKII as a Therapeutic Target in Cardiovascular Disease

    Authors: Oscar E. Reyes Gaido, Lubika J. Nkashama, Kate L. Schole, Qinchuan Wang, Priya Umapathi, Olurotimi Mesubi, Klitos Konstantinidis, Elizabeth D. Luczak, Mark E. Anderson - The Annual Review of Pharmacology and Toxicology 2022 cited by 128

  3. CaMKII determines mitochondrial stress responses in heart

    Authors: Mei-ling A. Joiner, Olha M. Koval, Jingdong Li, B. Julie He, Chantal Allamargot, Zhan Gao, Elizabeth D. Luczak, Duane D. Hall, Brian D. Fink, Biyi Chen, Jinying Yang, Steven A. Moore, Thomas Scholz, Stefan Strack, Peter J. Mohler, William I. Sivitz, Long‐Sheng Song, Mark E. Anderson - Nature 2012 cited by 405

  4. Excessive O -GlcNAcylation Causes Heart Failure and Sudden Death

    Authors: Priya Umapathi, Olurotimi Mesubi, P. S. Banerjee, Neha Abrol, Qinchuan Wang, Elizabeth D. Luczak, Yuejin Wu, Jonathan Granger, An‐Chi Wei, Oscar E. Reyes Gaido, Liliana Florea, C. Conover Talbot, Gerald W. Hart, Natasha E. Zachara, Mark E. Anderson - Circulation 2021 cited by 132

  5. Oxidized Ca 2+ /Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation

    Authors: Anil Purohit, Adam G. Rokita, Xiaoqun Guan, Biyi Chen, Olha M. Koval, Niels Voigt, Stefan Neef, Thomas Sowa, Zhan Gao, Elizabeth D. Luczak, Hrafnhildur Stefansdottir, Andrew C. Behunin, Na Li, Ramzi El Accaoui, Baoli Yang, Paari Dominic Swaminathan, Robert M. Weiss, Xander H.T. Wehrens, Long‐Sheng Song, Dobromir Dobrev, Lars S. Maier, Mark E. Anderson - Circulation 2013 cited by 313

  6. Mechanisms of Altered Ca 2+ Handling in Heart Failure

    Authors: Min Luo, Mark E. Anderson - Circulation Research 2013 cited by 358

  7. An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor

    Authors: Oscar E. Reyes Gaido, Nikoleta Pavlaki, Jonathan Granger, Olurotimi Mesubi, Bian Liu, Brian L. Lin, Alan Long, David Walker, Joshua Mayourian, Kate L. Schole, Chantelle E. Terrillion, Lubika J. Nkashama, Mohit Hulsurkar, Lauren E. Dorn, Kimberly Ferrero, Richard L. Huganir, Frank U. Müller, Xander H.T. Wehrens, Jun O. Liu, Elizabeth D. Luczak, Vassilios J. Bezzerides, Mark E. Anderson - Science Translational Medicine 2023 cited by 61

  8. Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy

    Authors: Elizabeth D. Luczak, Yuejin Wu, Jonathan Granger, Mei-ling A. Joiner, Nicholas R. Wilson, Ashish Gupta, Priya Umapathi, Kevin R. Murphy, Oscar E. Reyes Gaido, Amin Sabet, Eleonora Corradini, Wen-Wei Tseng, Yibin Wang, Albert J. R. Heck, An‐Chi Wei, Robert G. Weiss, Mark E. Anderson - Nature Communications 2020 cited by 89

  9. Sudden Cardiac Death Prediction and Prevention

    Authors: Glenn I. Fishman, Sumeet S. Chugh, John Dimarco, Christine M. Albert, Mark E. Anderson, Robert O. Bonow, Alfred E. Buxton, Peng‐Sheng Chen, Mark Estes, Xavier Jouven, Raymond Y. Kwong, David A. Lathrop, Alice M. Mascette, Jeanne M. Nerbonne, Brian O’Rourke, Richard L. Page, Dan M. Roden, David Rosenbaum, Nona Sotoodehnia, Natalia A. Trayanova, Zhi-Jie Zheng - Circulation 2010 cited by 605

  10. Calmodulin kinase II–mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice

    Authors: Mihail G. Chelu, Satyam Sarma, Subeena Sood, Sufen Wang, Ralph J. van Oort, Darlene G. Skapura, Na Li, Marco Santonastasi, Frank U. Müller, Wilhelm Schmitz, Ulrich Schotten, Mark E. Anderson, Miguel Valderrábano, Dobromir Dobrev, Xander H.T. Wehrens - Journal of Clinical Investigation 2009 cited by 418

  11. CaMKII in myocardial hypertrophy and heart failure

    Authors: Mark E. Anderson, Joan Heller Brown, Donald M. Bers - Journal of Molecular and Cellular Cardiology 2011 cited by 467

  12. Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways

    Authors: Jenelle M. Timmins, Lale Özcan, Tracie A. Seimon, Gang Li, Cristina Malagelada, Johannes Backs, Thea Backs, Rhonda Bassel‐Duby, Eric N. Olson, Mark E. Anderson, Ira Tabas - Journal of Clinical Investigation 2009 cited by 420

  13. Calmodulin-Dependent Protein Kinase II: Linking Heart Failure and Arrhythmias

    Authors: Paari Dominic Swaminathan, Anil Purohit, Thomas J. Hund, Mark E. Anderson - Circulation Research 2012 cited by 278

  14. Inhibition of MCU forces extramitochondrial adaptations governing physiological and pathological stress responses in heart

    Authors: Tyler P. Rasmussen, Yuejin Wu, Mei-ling A. Joiner, Olha M. Koval, Nicholas R. Wilson, Elizabeth D. Luczak, Qinchuan Wang, Biyi Chen, Zhan Gao, Zhiyong Zhu, Brett A. Wagner, Jamie Soto, Michael L. McCormick, William Kutschke, Robert M. Weiss, Liping Yu, Ryan L. Boudreau, E. Dale Abel, Fenghuang Zhan, Douglas R. Spitz, Garry R. Buettner, Long‐Sheng Song, Leonid V. Zingman, Mark E. Anderson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 162

  15. Oxidized CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms

    Authors: Olurotimi Mesubi, Adam G. Rokita, Neha Abrol, Yuejin Wu, Biyi Chen, Qinchuan Wang, Jonathan Granger, Anthony Tucker-Bartley, Elizabeth D. Luczak, Kevin R. Murphy, Priya Umapathi, P. S. Banerjee, Tatiana Boronina, Robert N. Cole, Lars S. Maier, Xander H.T. Wehrens, Joel L. Pomerantz, Long‐Sheng Song, Rexford S. Ahima, Gerald W. Hart, Natasha E. Zachara, Mark E. Anderson - Journal of Clinical Investigation 2020 cited by 78

  16. T-Tubule Remodeling During Transition From Hypertrophy to Heart Failure

    Authors: Wei Sheng, Ang Guo, Biyi Chen, William Kutschke, Yuping Xie, Kathy Zimmerman, Robert M. Weiss, Mark E. Anderson, Heping Cheng, Long‐Sheng Song - Circulation Research 2010 cited by 392

  17. CaMKII oxidative activation and the pathogenesis of cardiac disease

    Authors: Elizabeth D. Luczak, Mark E. Anderson - Journal of Molecular and Cellular Cardiology 2014 cited by 151

  18. Ryanodine Receptor Phosphorylation by Calcium/Calmodulin-Dependent Protein Kinase II Promotes Life-Threatening Ventricular Arrhythmias in Mice With Heart Failure

    Authors: Ralph J. van Oort, Mark McCauley, Sayali S. Dixit, Laëtitia Pereira, Yi Yang, Jonathan L. Respress, Qiongling Wang, Angela C. De Almeida, Darlene G. Skapura, Mark E. Anderson, Donald M. Bers, Xander H.T. Wehrens - Circulation 2010 cited by 305

  19. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone

    Authors: B. Julie He, Mei-ling A. Joiner, Madhu V. Singh, Elizabeth D. Luczak, Paari Dominic Swaminathan, Olha M. Koval, William Kutschke, Chantal Allamargot, Jinying Yang, Xiaoqun Guan, Kathy Zimmerman, Isabella M. Grumbach, Robert M. Weiss, Douglas R. Spitz, Curt D. Sigmund, W. Matthijs Blankesteijn, Stéphane Heymans, Peter J. Mohler, Mark E. Anderson - Nature Medicine 2011 cited by 237

  20. MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction

    Authors: Madhu V. Singh, Paari Dominic Swaminathan, Elizabeth D. Luczak, William Kutschke, Robert M. Weiss, Mark E. Anderson - Journal of Molecular and Cellular Cardiology 2012 cited by 147

  21. Metabolite identification via the Madison Metabolomics Consortium Database

    Authors: Qiu Cui, Ian A. Lewis, Adrian D. Hegeman, Mark E. Anderson, Jing Li, Christopher Schulte, William M. Westler, Hamid R. Eghbalnia, Michael R. Sussman, John L. Markley - Nature Biotechnology 2008 cited by 639

  22. Calmodulin kinase II inhibition protects against structural heart disease

    Authors: Rong Zhang, Michelle S.C. Khoo, Yuejin Wu, Yingbo Yang, Chad E. Grueter, Gemin Ni, Edward Price, William H. Thiel, Sílvia Guatimosim, Long‐Sheng Song, Ernest C. Madu, Anisha N Shah, Tatiana A. Vishnivetskaya, James B. Atkinson, Vsevolod V. Gurevich, Guy Salama, W. Jonathan Lederer, Roger Colbran, Mark E. Anderson - Nature Medicine 2005 cited by 571

  23. Diabetes increases mortality after myocardial infarction by oxidizing CaMKII

    Authors: Min Luo, Xiaoqun Guan, Elizabeth D. Luczak, Di Lang, William Kutschke, Zhan Gao, Jinying Yang, Patric Glynn, Samuel Sossalla, Paari Dominic Swaminathan, Robert M. Weiss, Baoli Yang, Adam G. Rokita, Lars S. Maier, Igor R. Efimov, Thomas J. Hund, Mark E. Anderson - Journal of Clinical Investigation 2013 cited by 233

  24. E-C coupling structural protein junctophilin-2 encodes a stress-adaptive transcription regulator

    Authors: Ang Guo, Yihui Wang, Biyi Chen, Yunhao Wang, Jinxiang Yuan, Liyang Zhang, Duane D. Hall, Jennifer D. Wu, Yun‐Bo Shi, Qi Zhu, Cheng Chen, William H. Thiel, Xin Zhan, Robert M. Weiss, Fenghuang Zhan, Catherine A. Musselman, Miles A. Pufall, Weizhong Zhu, Kin Fai Au, Hong Jiang, Mark E. Anderson, Chad E. Grueter, Long‐Sheng Song - Science 2018 cited by 115